Computational studies of potent covalent inhibitors on wild type or T790M/L858R mutant epidermal growth factor receptor
- 1 September 2020
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 152, 105463
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (21603095)
- General guidance project of Guangzhou health science and technology (20191A010065)
This publication has 55 references indexed in Scilit:
- Structure- and Reactivity-Based Development of Covalent Inhibitors of the Activating and Gatekeeper Mutant Forms of the Epidermal Growth Factor Receptor (EGFR)Journal of Medicinal Chemistry, 2013
- Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics SimulationsJournal of Chemical Information and Modeling, 2010
- Improved side‐chain torsion potentials for the Amber ff99SB protein force fieldProteins: Structure, Function, and Bioinformatics, 2010
- Novel mutant-selective EGFR kinase inhibitors against EGFR T790MNature, 2009
- Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitorsOncogene, 2009
- Clinical Efficacy and Toxicity of Anti-EGFR Therapy in Common CancersJournal of Oncology, 2009
- The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATPProceedings of the National Academy of Sciences, 2008
- Epidermal growth factor receptor mutations in lung cancerNature Reviews Cancer, 2007
- The discovery of receptor tyrosine kinases: targets for cancer therapyNature Reviews Cancer, 2004
- Development and testing of a general amber force fieldJournal of Computational Chemistry, 2004